Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies

Background: Low-dose prescription of rivaroxaban was common among patients with atrial fibrillation (AF) in Asia. However, the benefits and harms of rivaroxaban at a low dosage in Asian patients with AF remains unclear. Accordingly, we aimed to collect and summarize all available evidence to fill th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jun, Yan, Yi-Dan, Yang, Sheng-Yan, Zhang, Chi, Li, Wen-Yan, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240755/
https://www.ncbi.nlm.nih.gov/pubmed/34211392
http://dx.doi.org/10.3389/fphar.2021.642907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240755/
https://www.ncbi.nlm.nih.gov/pubmed/34211392
http://dx.doi.org/10.3389/fphar.2021.642907

Ejemplares similares